Regadenoson is the first selective A2A receptor agonist that is approved by the FDA and is currently used clinically.
Product Name: Regadenoson |Catalog Number: DC8752 |CAS 313348-27-5 |Other names: Lexiscan; CVT-3146; |Chemical Name: |Molecule Formular: C15H18N8O5 |MW: 390.35
Regadenoson is the first selective A2A receptor agonist that is approved by the FDA and is currently used clinically.
For research only, not for human use!
没有评论:
发表评论